TP53 and acute myeloid leukemia: In addition, some studies have found that drug-resistant AML cells may be able to inhibit the proliferation of cells through the upregulation of certain genes associated with cell cycle arrest genes, such as TP53, to resist the induction of apoptosis by Ara-C (DiNardo et al., 2020a; Grob et al., 2022).